This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together with its expert network on drug-related infectious diseases (DRID), as a follow-up to the first global health sector strategy on viral hepatitis endorsed by the World Health Assembly in 2016. The elimination barometer includes five building blocks (context and needs, inputs, prevention, testing and linkage to care, and impact) and 17 indicators covering the EU, Norway and Turkey.
La Comisión Europea está preparando una tercera fase de este programa, por lo que COPOLAD volverá a principios de 2021.